Mednet Logo
HomeGynecologic OncologyQuestion

Would you alter neoadjuvant chemotherapy regimen for a high grade small cell neuroendocrine carcinoma of the ovary if she has already received cycle 1 of carbo/taxol?

1 Answers
Mednet Member
Mednet Member
Gynecologic Oncology · Columbia University Medical Center

Small cell neuroendocrine tumors of the ovary are rare and of poor prognosis. There are several steps I would take in a situation like the one described in the vignette.

  1. Discuss poor prognosis with the patient.
  2. Rule out occult primary that is not ovarian.
  3. Get early involvement of medical oncologis...

Register or Sign In to see full answer

Would you alter neoadjuvant chemotherapy regimen for a high grade small cell neuroendocrine carcinoma of the ovary if she has already received cycle 1 of carbo/taxol? | Mednet